The CIHR is recruiting members to join one of its 13 Institute Advisory Boards! (IABs)

The Canadian Institutes of Health Research (CIHR) is recruiting members to join one of its 13 Institute Advisory Boards (IABs).

IABs are composed of dedicated volunteers from Canada and abroad with a wide range of experience and expertise in various areas related to health, health research, health policy, and lived experience. They provide advice and guidance to CIHR’s institutes. New members will be invited to serve a first term of three years beginning on January 1, 2025. IABs meet at least twice yearly, and members will be reimbursed for travel and accommodation.

Diversity of experience and representation are critical to the success of IABs. We encourage members from all communities to apply, especially those from Indigenous, Francophone and equity-denied communities, LGBTQ2S+ communities, and persons with disabilities. Patients, advocates, and individuals with lived experience are also encouraged to apply.   

 For more information, please visit our CIHR webpage and our Application webpage. Applications will be accepted until April 25, 2024

If you have any questions, you may contact CIHR at IAB-CCI@cihr-irsc.gc.ca.

Celebrating International Women’s Day!

Celebrating #InternationalWomensDay2024 today. A big shout out to all the remarkable women on our committees, board of directors, and operations team who make a difference with #N2Canada and the #ClinicalResearch landscape

CAN TAP TALENT Awards Update!

We are excited to announce our EDIA Summer Student Awards and Travel Awards are now live! The new cycle of Master, PHD and Post Doctoral award guidelines are also posted.

Student Award Applications are due Friday March 29th and results will be announced on April 15th. Guidelines and funding information can be found on the CAN TAP TALENT website: https://can-stat.ca/

N2 is a Proud Partner of RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network

In Canada, 14,000 children under the age of 15 die each year from a rare disease. With more than 7,000 known rare diseases, it is essential for researchers from across the country to work together to improve the health outcomes of all children and teens living with a rare disease.

That is why today, the Honourable Mark Holland, Minister of Health, announced the Government of Canada is providing $20 million over five years to Dr. Thierry Lacaze-Masmonteil and the Maternal Infant Child and Youth Research Network (MICYRN) team, to create RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network.

The national Network will foster collaboration among researchers, patients, caregivers, health care providers, and policy makers; streamline clinical research; and support national and international clinical trials to advance discoveries, enable better prevention, diagnosis, and treatments, to improve health outcomes for children and adolescents affected by rare diseases.

This investment was funded through the Canadian Institutes of Health Research Rare Disease Research Initiative, one of many initiatives funded through the Government of Canada’s National Strategy for Drugs for Rare Diseases.

The federal government will continue to make investments like these to support Canadian researchers who are working hard to improve health outcomes people living in Canada and elsewhere in the world.